If eligible, MinuteClinic providers will determine the best weight-loss medications for you
Because oral semaglutide has a bioavailability of roughly 0.4% to 1%
Despite the breadth of knowledge on the role of the endocannabinoid system in appetite, body weight, and obesity, there is a paucity of preclinical or human studies on the link between cannabis use and GLP-1
GLP-1 provides systemic metabolic benefits: Reduced Visceral Fat: GLP-1 preferentially mobilizes harmful visceral adiposity (fat around organs), which drives inflammation and cardiometabolic disease
The patterns it shows will be central to any decision
case-by-case assessment) Severe uncontrolled depression, anxiety, or eating disorders (risk of worsening) Pregnancy or intent to become pregnant (GLP-1 safety in pregnancy not established